Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-05-18

Clinical Trial Update: Combination Chemotherapy With or Without Rituximab in Treating Older Patients With Non-Hodgkin's Lymphoma [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating combination chemotherapy with or without rituximab in older adults with non-Hodgkin's lymphoma; completed study.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Rituximab (rituximab)

Snippet

Sponsor: German High-Grade Non-Hodgkin's Lymphoma Study Group | Conditions: Lymphoma | Phase 3 | Status: COMPLETED